Association of Apolipoprotein B with Incident Type 2 Diabetes in an Aboriginal Canadian Population1 | Zendy

Sylvia H. Ley | Zendy; Stewart B. Harris | Zendy; Philip W. Connelly | Zendy; Mary Mamakeesick | Zendy; Joel Gittelsohn | Zendy; Thomas M.S. Wolever | Zendy; Robert A. Hegele | Zendy; Bernard Zinman | Zendy; Anthony J. Hanley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Apolipoprotein B with Incident Type 2 Diabetes in an Aboriginal Canadian Population1

Author(s) -

Sylvia H. Ley,

Stewart B. Harris,

Philip W. Connelly,

Mary Mamakeesick,

Joel Gittelsohn,

Thomas M.S. Wolever,

Robert A. Hegele,

Bernard Zinman,

Anthony J. Hanley

Publication year - 2010

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2009.136994

Subject(s) - medicine , type 2 diabetes , diabetes mellitus , odds ratio , apolipoprotein b , univariate analysis , cholesterol , endocrinology , incidence (geometry) , cohort , cumulative incidence , gastroenterology , multivariate analysis , physics , optics

Expanding evidence indicates that apolipoprotein B (apo B) is superior to LDL cholesterol as a marker of vascular disease. Although traditional lipid measures are known to predict type 2 diabetes, limited data are available regarding apo B. We assessed the association of apo B with incident type 2 diabetes and compared it with traditional lipid variables as a risk predictor in aboriginal Canadians.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research